A unique Harvard program trains future physicians to recognize structural failures embedded within our health care system.
What is happiness? According to Laurie R. Santos, MA, PhD, social scientists define it as “the idea that you want to be happy ...
Pharmaceutical Technology on MSNOpinion
Real-time data: how to gain an edge amid clinical services consolidation
Amanda Murphy, senior director at GlobalData shares how companies can ensure success amidst consolidation in the clinical ...
Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...
TCT 1167: Feasibility of Transcatheter Aortic Valve Replacement Using a Balloon Expandable Valve in Patients with Prior Endovascular Aortic Stent Grafts Receive the the latest news, research, and ...
– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS ...
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung ...
Background: Optimisation of Deep Brain Stimulation (DBS) settings is a key aspect in achieving clinical efficacy in movement disorders, such as the Parkinson’s disease. Modern techniques attempt to ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...
“Half of my week is spent now on data center-related issues," said Vinson & Elkins energy regulatory partner Jeffrey Jakubiak. As the use of artificial intelligence technology continues to explode, ...
The MarketWatch News Department was not involved in the creation of this content. Los Angeles, California--(Newsfile Corp. - September 26, 2025) - Novian & Novian, LLP, a California-based law firm, ...
SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback